Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.24 | 0.2 |